Supporting these findings are the results of a breast cancer report, demonstrating that ACKR4 overexpression by breast tumor cells inhibited tumor growth and lung metastases, and decreased the expression of mouse CCL19, CCL21, CCL25 and CXCL13 chemokines in xenografts (208). This evidence concerns the gene ACKR4 and neoplasm.